These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 12571734)

  • 21. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004).
    Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ
    Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in reducing measles mortality--worldwide, 1999-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Mar; 54(8):200-3. PubMed ID: 15744229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008.
    van den Ent MM; Brown DW; Hoekstra EJ; Christie A; Cochi SL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S18-23. PubMed ID: 21666160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles control in India.
    Mohan P; Dabi DR
    Indian Pediatr; 1997 Dec; 34(12):1137-9. PubMed ID: 9715564
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(24):513-6. PubMed ID: 11432675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 31. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-specific effect of measles vaccination on all-cause child mortality: revisited.
    Kabir Z; Aaby P
    Indian Pediatr; 2005 Jun; 42(6):541-4. PubMed ID: 15995270
    [No Abstract]   [Full Text] [Related]  

  • 33. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress towards elimination of measles in the Americas. WHO expanded programme on immunization.
    Can Commun Dis Rep; 1998 Jun; 24(11):94-6. PubMed ID: 9629836
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles vaccination coverage and reasons for non-vaccination.
    Torun SD; Demir F; Hidiroglu S; Kalaca S
    Public Health; 2008 Feb; 122(2):192-4. PubMed ID: 17825861
    [No Abstract]   [Full Text] [Related]  

  • 36. Progress in reducing global measles deaths, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(9):247-9. PubMed ID: 16528234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The global burden of measles in the year 2000--a model that uses country-specific indicators.
    Stein CE; Birmingham M; Kurian M; Duclos P; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S8-14. PubMed ID: 12721886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary and conclusions: measles elimination meeting, 16-17 March 2000.
    Katz SL; Hinman AR
    J Infect Dis; 2004 May; 189 Suppl 1():S43-7. PubMed ID: 15106088
    [No Abstract]   [Full Text] [Related]  

  • 39. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
    Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.